Valhalla Venture Group, LLC - Harvest

Valhalla Venture Group, LLC

A UNIQUE ORGANIZATION DEDICATED TO BUILDING MARKET VALUE, INVESTMENT PROFILE AND MARKETING POWER IN MICRO-CAP AND SMALL-CAP COMPANIES.

Firm at a glance Leadership Insights

Firm at a Glance

FIRM TYPE

Asset Manager

LOCATION

Port Jefferson, New York

FOUNDED

2013

WEBSITE

Leadership

John Austin, Valhalla Venture Group, LLC

Partner at Valhalla Venture Group

Search Insights...

John Austin, Valhalla Venture Group, LLC

KoreSummit NYC 2018

#BlockChainGlobal is proud to be the media partner for KoreSummit NY 2018. Join us in NYC October 3rd at 1:00pm. #SecurityTokenSummit #KoreSummit

Sep 27, 2018

John Austin, Valhalla Venture Group, LLC

Biotech Company Focus: MabVax Therapeutics (NASDAQ: MBVX)

Sep 20, 2016

John Austin, Valhalla Venture Group, LLC

SCN's Jane King Interviews CEO Mitch Geisler of Medical Imaging Corp., (OTC: MEDD)

Aug 24, 2016

John Austin, Valhalla Venture Group, LLC

Small Cap Nation’s Jane King interviews Dr Eugene Seymour, CEO of NanoViricides

Mar 18, 2016

John Austin, Valhalla Venture Group, LLC

Reinsurance, the Perfect Hedge Fund Strategy to Diversify a Portfolio

Mar 06, 2016

John Austin, Valhalla Venture Group, LLC

David Siegel CEO, @Investopedia and Craig Kaufman Discuss Idea Generation '16 Investment Conference

Feb 28, 2016

John Austin, Valhalla Venture Group, LLC

Jane King Interviews Craig Kaufman About Upcoming Idea Generation '16 Investment Conference

http://hvst.co/1QkU4Z9

Feb 17, 2016

John Austin, Valhalla Venture Group, LLC

CBMG Secures 43 Million Dollar Injection of Capital

Feb 10, 2016

John Austin, Valhalla Venture Group, LLC

EXCLUSIVE SCN Interview: W/ Family Office Networks Co-Founder, Steven Saltzstein interview with Jane King at NYSE

Family Office Networks is a unique collection of different Family Offices located throughout the world that is able to bring the financial industry and financial professionals to various single family and multi-family office locations.

Feb 03, 2016

John Austin, Valhalla Venture Group, LLC

The FDA Approved Eisai's Latest Drug - on SCN News.

The FDA approved Eisai's (@OTCMKTS: $ESALY) drug for treating a rare type of soft tissue cancer called Liposarcom. It had no approved treatments and occurs in 12,000 Americans each year.

Feb 02, 2016

John Austin, Valhalla Venture Group, LLC

George Zavoico talks to Immune Pharma (IMNP) CEO Dr. Daniel Teper

Jan 26, 2016

John Austin, Valhalla Venture Group, LLC

Jason Napodano from BioNap talks Forces Weighing on the BioTech Market

Remy Blaire catches up with Jason Napodano to discuss BioNap in 2016 and the forces weighing on the BioTech Market.

Jan 19, 2016

John Austin, Valhalla Venture Group, LLC

News Years Selloff But Small Cap Stocks Up on The Year. KalaBios Pharma BKs on Shkreli Indictment!

Jan 06, 2016

Global Climate Investing Survey 2025

Sponsored by Robeco

Our fifth annual survey shows that enthusiasm for climate investment continues to vary by region. Europe has reclaimed its leadership from Asia-Pacific, which topped last year’s survey, while interest in the US has dropped to new lows.

The most important insight of the day

Get the Harvest Daily Digest newsletter.

Support
Privacy Policy
GDPR
CCPA
Terms
Copyright

© 2025 Harvest Exchange Corp

What is Harvest?

Harvest is a digital marketing platform that connects investors with financial firms, products and services through behavioral data.

Become a publisher

Distribute your firm's investment insights on the world's largest investor community. Learn more